HealthCert Blog

A Lancet paper reporting a favourable risk-benefit profile for SC methotrexate (although perhaps not as effective as biologicals) for treating patients with moderate-to-severe plaque psoriasis begins the March research review on dermatology. Belgian research suggests that a one-time total-body skin examination of adults is the most cost-effective strategy for reducing skin cancer mortality. This is followed by Australian research on skin cancer, with Queensland researchers reporting on the anatomical distributions of SCCs and BCCs seen among their patients. This issue concludes with interesting research suggesting that broccoli sprout extract may provide some benefit for patients with keratin-based disorders, although much more research is needed.

Featured in this issue:

• Intensified SC methotrexate for moderate-to-severe plaque psoriasis
• Costs and consequences of misdiagnosed lower-leg cellulitis
• Economic analyses of population-based skin cancer screening
• Anatomical distributions of BCCs and SCCs in Queensland
• IBD in ixekizumab-treated psoriasis
• Hair pull test: guidelines update
• Corticosteroid-responsive erythromelalgia
• First-line doxycycline vs. prednisolone for bullous pemphigoid
• Migraine in rosacea
• Topical broccoli sprout extract for keratin-based disorders

Click here to download the full paper 

Interested in General Dermatology?

The HealthCert Professional Diploma of General Dermatology will teach you how to manage all major dermatological conditions in primary care. The courses are university quality-assured, CPD-accredited and count towards multiple Master degree pathways and clinical attachment programs in Australia and overseas. The program is delivered online.